https://www.templehealth.org/doctors/benjamin-slovis
Education MD, Robert Wood Johnson Medical School, New Brunswick, NJ
https://alumni.temple.edu/TUAANightatthePhillies2025
Registration Fee: $35 per guest* - For Pregame Reception ONLY *Please note that the pregame reception fee does NOT include a game ticket. More game ticket info below: Temple Sections: Pavilion (Sections 201-205) Pavilion (Sections 206-211) Pavilion Deck (Sections 306-310) Purchase game tickets here to sit within the Temple University Night game sections (Sections 201-310)! Event Description ...
https://www.liacourascenter.com/?ref=w3use
Posted Sep 22, 2025 TOBYMAC'S HITS DEEP 2026 ANNOUNCED WITH ARTISTS CROWDER AND JEREMY CAMP Posted Jul 2, 2025 Black Cowboys Take Center Stage: 8 Seconds Rodeo Expands for Its Biggest Year Yet With A Stop In Philadelphia! Posted Jun 24, 2025 “The World of Hans Zimmer - A New Dimension” 24-City North American Arena Tour Comes to Philadelphia
https://www.temple.bncollege.com/?parentCatId=40354&categoryId=40483&catalogId=10001&langId=-1&parentSubCatIdFlag=true&storeId=11558&topCatId=40351?parentCatId=40354&categoryId=40483&catalogId=10001&langId=-1&parentSubCatIdFlag=true&storeId=11558&topCatId=40351
www.temple.bncollege.com
https://dabi.temple.edu/external/disprot/resource.php
Thus, the existence of disorder is determined by a protein's dynamical properties, and not necessarily by the presence or absence of local secondary structure. We define an intrinsically disordered protein as one that contains at least one disordered region.
https://templetv.net/shows/temple-tonight/
Temple Tonight is TUTV's first late-night talk show, featuring a house band, stand up comedy, interviews, musical performances, and more!
https://owlsports.com/news/2025/2/3/mens-basketball-jamal-mashburn-jr-named-aac-player-of-the-week
PHILADELPHIA - Graduate student Jamal Mashburn Jr . was named the American Athletic Conference Men's Basketball Player of the Week, it was announced by the l...
https://www.templehealth.org/services/lung/research-clinical-trials/pillar
A 52-week, Randomized, Double-blind, Double-dummy, Placebo- and Active- Controlled (Roflumilast, Daliresp® 500µg), Parallel Group, Study to Evaluate the Efficacy and Safety of Two Doses of CHF6001 DPI add-on to Maintenance Triple Therapy in Subjects With Chronic Obstructive Pulmonary Disease (COPD) and Chronic Bronchitis.
https://noncredit.temple.edu/funds
Cancellations received nine (9) business days to one (1) business day prior to the start of the scheduled course will be subject to a cancellation charge of $10.00 for one day/session courses and $50.00 for multiday courses.
https://www.templehealth.org/services/lung/research-clinical-trials/study-evaluating-safety-and-efficacy-of-ap01-in-participants-with-progressive-pulmonary-fibrosis
A randomized, double-blind, placebo-controlled clinical study to evaluate the safety and efficacy of 2 doses of AP01 versus placebo on top of standard of care in participants with PPF over 52 weeks.